Keryx Proxy Action Ignored 'Tailored Warning,' Judge Says
A Delaware federal judge on Wednesday dismissed a shareholder's proposed class action alleging Keryx Biopharmaceuticals Inc. misled the public in the lead-up to a December 2018 shareholder vote on the company's...To view the full article, register now.
Already a subscriber? Click here to view full article